Noninvasive treatment for shoulder pain linked to liver issues
Effectiveness of Noninvasive Phrenic Nerve Neuromodulation in Subjects With Right Shoulder Pain and Hepatobiliary Visceral Comorbidity.
This study is testing a new noninvasive treatment for shoulder pain that might be linked to liver problems to see if it can help relieve the pain.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 34 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Seville Academic / other |
| Locations | 4 sites (Seville, Sevilla and 3 other locations) |
| Trial ID | NCT06296979 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of noninvasive phrenic nerve neuromodulation in treating shoulder pain that may be related to hepatobiliary visceral disorders. It aims to understand how visceral conditions can cause referred pain in the shoulder area and whether neuromodulation can alleviate this pain. The approach involves assessing patients with right shoulder pain and associated liver conditions, utilizing both neuromodulation techniques and physical therapy as interventions.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with right shoulder pain and a diagnosed hepatobiliary disorder.
Not a fit: Patients with chronic pain from other diseases, such as malignancies or rheumatic diseases, may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide significant relief for patients suffering from shoulder pain linked to liver conditions.
How similar studies have performed: While the concept of visceral referred pain is established, this specific approach to phrenic nerve neuromodulation is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over 18 years of age. * Subjects presenting right shoulder pain at the time of enrollment in the study. * Presentation of a hepatobiliary visceral disorder that may justify the visceral etiology of the pain. * That they agree to participate in the project by signing the informed consent form. Exclusion Criteria: * Patients with chronic pain due to other diseases such as malignant disease. * Patients with rheumatic diseases. * Cutaneous infection in the area of pain. * Disease of neurological, traumatic, oncologic, or infectious origin that rules out the visceral origin of the pain. * Uncooperative subject. * Severe psychiatric disease. * Loss of cognitive capacity. * Contraindication to electrotherapy.
Where this trial is running
Seville, Sevilla and 3 other locations
- Centro de Salud Ronda Histórica — Seville, Sevilla, Spain (Recruiting)
- Centro de Salud las Letanías — Seville, Sevilla, Spain (Recruiting)
- Centro de Salud Bellavista — Seville, sevilla, Spain (Recruiting)
- Centro de especialidades Morón de la Frontera — Morón de la Frontera, Seville, Spain (Recruiting)
Study contacts
- Principal investigator: Ángel Oliva Pascual-Vaca, Dr — University of Seville
- Study coordinator: Adolfo Rosado Portillo
- Email: adolforosadoportillo@gmail.com
- Phone: 605663879
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.